Molecular Pharmacology (USA), Ltd.
MLPH · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $100 | $100 | $900 | $1,199 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $100 | $100 | $900 | $1,199 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$1 | -$5 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$1 | -$5 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | 0 | 0 | 0 |
| % Growth | – | – | – | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |